about
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalMetabolic Alterations Associated to Brain Dysfunction in DiabetesDiabetes and Cognitive Impairment.Early effects of a high-caloric diet and physical exercise on brain volumetry and behavior: a combined MRI and histology study in mice.Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats.Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus.Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathyHyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabeticsNear normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation.The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes.The Protective Effect of Radix Polygoni Multiflori on Diabetic Encephalopathy via Regulating Myosin Light Chain Kinase Expression.Astroglial pentose phosphate pathway rates in response to high-glucose environments.Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes.Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.Diabetes and the elderly brain: sweet memories?Understanding the diabetic brain: new technologies but old challenges.The unfolded protein response to endoplasmic reticulum stress in cultured astrocytes and rat brain during experimental diabetes.Sildenafil Ameliorates Advanced Glycation End Products-Induced Mitochondrial Dysfunction in HT-22 Hippocampal Neuronal Cells.Cerebrovascular complications of diabetes: focus on stroke.Streptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in mice.Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes.Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.Coenzyme Q10 and niacin mitigate streptozotocin- induced diabetic encephalopathy in a rat model.50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study.Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus.Protein modification by dicarbonyl molecular species in neurodegenerative diseases.Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway.Protective effects of Salvia miltiorrhiza injection against learning and memory impairments in streptozotocin-induced diabetic rats.F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline.Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats.Enhancement of high glucose-induced PINK1 expression by melatonin stimulates neuronal cell survival: Involvement of MT2 /Akt/NF-κB pathway.L-type calcium channel blocker ameliorates diabetic encephalopathy by modulating dysregulated calcium homeostasis.A novel thiazolidinediones ATZD2 rescues memory deficits in a rat model of type 2 diabetes through antioxidant and antiinflammation.Enriched environment induces beneficial effects on memory deficits and microglial activation in the hippocampus of type 1 diabetic rats.Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications.Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat.Vascular and neuronal protection induced by the ocular administration of nerve growth factor in diabetic-induced rat encephalopathy.Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose.
P2860
Q26783344-2DE58D04-5455-4212-A294-399017D60540Q26783376-FE34C1ED-DE0A-4733-80D2-CDF644EC84DFQ31119662-FAA776FF-BCA1-4EB7-AF5E-FC512FBD9DD3Q33364089-561948F5-C7BA-482E-AFC2-899AE8292E6DQ33724132-C0EE8BAC-BB6C-416A-8C14-3D817F946675Q33994002-865826D3-A86A-41A6-A641-61ECD9967053Q35095336-1DB16C55-7C7A-49BE-A78A-77E002F077F0Q35560436-3878A3F3-6A51-4302-8294-662070F230AAQ35688334-27AECAA4-F481-4872-95FC-58B0916D2526Q35739470-2A03F731-7A03-4F2F-B35F-867EE6DF5183Q35833442-A5D0B56C-535B-450B-8658-EA6478055C9BQ35846489-251BBB63-9014-4EB3-9500-BBEAE847AC2FQ35879072-2D18A0E4-5370-45EB-ABD9-88D8389F0766Q36057624-19CDFCD9-59AC-40C3-BCED-863B254A9636Q36515189-474898E2-CD1B-4359-9D8F-5E8573BCFC97Q36560564-03E348DD-4F51-42D8-A067-9394B424B483Q36736253-ADABF251-A48A-46F7-A092-06778E779443Q36928366-27F4D122-C2A4-47AF-9DD6-33ABF513A8C6Q37089769-D2DB8F26-47CA-47BB-AA4F-735393D14ACEQ37140449-29905B16-0CE5-4328-9EBF-249299F6992AQ37403188-615184B3-9145-461B-B877-BAE1E9187CD8Q38182056-A1669D40-7A24-45A7-A808-F5D08D12E8E1Q38676912-41320FC3-71CD-4CA0-BFF4-C55789319C61Q39014705-CC42FB29-46D5-4C10-B692-7DAF0EDD0012Q40309071-A28EC2E3-5CA0-48FE-934C-AED200E344C7Q40942272-941EC538-6BD9-4AF2-B5C2-1387ACBF98E9Q40973301-818AF9B5-F724-49C7-BA0C-A332F35CDE1AQ41367811-618AEEED-5F33-4C8E-8210-86670F10AB1BQ41875622-B178672D-7D78-43DB-AF7F-F87251B2B1E0Q42718213-B82D15A9-95C8-4BBD-BD4F-E3E8E01F0D73Q43776154-31A0FD89-9867-4208-A084-F49D2E752430Q46356335-93D12381-8C4A-4A39-B467-3F689E9CC300Q46832266-94C0AEBE-D98C-4FF7-8400-37113A428119Q47136653-E5703FC0-DBED-4155-8ABF-60A5EE5C2B7BQ47822111-DC328CC1-A91B-47BE-B795-2F91FEE74EF6Q47870702-3884EDB5-C9C6-466E-A886-B23C7501B280Q47983600-B0168579-6B2E-4324-8F73-B9ADD88C7B5FQ48006992-9E271522-BA42-4A98-9132-EFEBA15D8903Q48110989-6BF58C8D-5A02-4C56-8066-AD73D78F3916Q49060270-8AB8BA89-31CD-4906-886C-97431052B34F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Encephalopathies: the emerging diabetic complications.
@en
Encephalopathies: the emerging diabetic complications.
@nl
type
label
Encephalopathies: the emerging diabetic complications.
@en
Encephalopathies: the emerging diabetic complications.
@nl
prefLabel
Encephalopathies: the emerging diabetic complications.
@en
Encephalopathies: the emerging diabetic complications.
@nl
P2860
P1433
P1476
Encephalopathies: the emerging diabetic complications.
@en
P2093
Anders A F Sima
P2860
P2888
P304
P356
10.1007/S00592-010-0218-0
P577
2010-08-27T00:00:00Z